Multiple Sclerosis Clinical Trials
A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 453 clinical trials
Multiple Sclerosis
LIVING WITH MULTIPLE SCLEROSIS?The purpose of this study is to find out the effect of the study drug, on the body in patients with MS by assessing your
- 0 views
- 28 Oct, 2021
- 1 location
A research study for patients who have been diagnosed with multiple sclerosis
A research study for patients who have been diagnosed with multiple sclerosis
- 399 views
- 23 Nov, 2020
- 1 location
A research study for patients who have been diagnosed with multiple sclerosis
A research study for patients who have been diagnosed with multiple sclerosis
- 807 views
- 23 Nov, 2020
- 1 location
Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis
Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis
- 397 views
- 08 Nov, 2020
- 1 location
Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.
Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.
- 428 views
- 08 Nov, 2020
- 1 location
An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing Arbaclofen Placarbil Safety in Subjects With Spasticity Associated With Multiple Sclerosis
An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing
- 199 views
- 08 Nov, 2020
- 1 location
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis
- 204 views
- 08 Nov, 2020
- 1 location
A Multicenter, Double-Blind, Placebo-Controlled Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving TECFIDERA® (Dimethyl Fumarate) Delayed-Release Capsules
A Multicenter, Double-Blind, Placebo-Controlled Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving TECFIDERA® (Dimethyl Fumarate
- 198 views
- 08 Nov, 2020
- 1 location
A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults Who Are in Early Stages of Treatment for Relapsing Remitting Multiple Sclerosis
Stages of Treatment for Relapsing Remitting Multiple Sclerosis
- 125 views
- 08 Nov, 2020
- 1 location
A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis
- 246 views
- 25 Mar, 2021
- 1 location